Following the Passage of California’s Assembly Bill 45, HempFusion Plans Retail Expansion
October 12 2021 - 7:05AM
Business Wire
HempFusion Family of Brands Already Meet or
Exceed Expected Guidelines
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF)
(FWB:8OO) (“HempFusion” or the “Company”), a leading health and
wellness Company offering premium probiotic supplements and
products containing CBD, applauds California’s Assembly Bill 45
permitting the retail sale of products containing hemp-derived
extracts and CBD. The Company and its family of brands plans to
immediately expand its already sizeable footprint in California,
the country’s most populous state.
“The 2018 Farm Bill removed hemp from the definition of
marijuana in the Controlled Substances Act. Now California has
passed Assembly Bill 45 that will allow California consumers to
purchase food, beverage, dietary supplements and cosmetics
manufactured with hemp-derived CBD” said Jason Mitchell, N.D.,
HempFusion‘s Co-Founder and Chief Executive Officer. “As one of the
most compliant CBD companies on the market, HempFusion's family of
brands already meet or exceed California’s new regulatory
requirements and welcomes this opportunity to quickly expand our
footprint in the state.”
“With an already large distribution footprint within retail
locations in California, we expect to continue to be one of the
leading companies in the state,” continued Dr. Mitchell. “Our
recently acquired female-focused brand, Sagely Naturals, was
founded in California and has built a strong reputation among
California consumers for safe and reliable premium hemp extract
products. Continued progress in California will help the Company
achieve its future revenue goals,” continued Dr. Mitchell.
ABOUT HEMPFUSION
One of a select few CBD companies who are today fully prepared
to meet or exceed expected FDA guidance, HempFusion Wellness Inc.
is a leading health and wellness company whose family of premium
consumer brands include HempFusion™, Sagely Naturals™,
Apothecanna™, and Probulin Probiotics™, one of the fastest-growing
probiotics companies in the United States according to SPINs
reported data.
Utilizing the power of whole-food hemp nutrition, the HempFusion
family of brands’ product portfolio comprises 112 SKUs including
USDA Organic Certified Tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, probiotic supplements and skin
care products, a Doctor/Practitioner line, a White Label division
and more. With a strong focus on research and development,
HempFusion Wellness has 43 products under development.
Available from more than 15,000 US retail locations across all
50 states, HempFusion Wellness products are also available in
China, Mexico, Ireland, United Kingdom, United Arab Emirates, South
Korea and Canada and may be purchased online from each brand’s
website, The Probulin Store on Amazon.com, Alibaba’s Tmall.com, the
world’s largest cross-border online marketplace, and a multitude of
additional e-commerce sites.
For more information, visit www.hempfusion.com and follow
HempFusion on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements“) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result”,
“are expected to”, “expects”, “will continue”, “is anticipated”,
“anticipates”, “believes”, “estimated”, “intends”, “plans”,
“forecast”, “projection”, “strategy”, “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to the
Company’s expansion plans, compliance with expected regulatory
requirements and guidelines, achievement of revenue goals and the
Company’s other plans, focus and objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Cautionary Note Regarding Forward-Looking Statements”
and “Risk Factors” in the annual information form of the Company
dated March 31, 2021, and available under the Company’s profile on
SEDAR at www.sedar.com. HempFusion undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
may be required by law. New factors emerge from time to time, and
it is not possible for HempFusion to predict all of them or assess
the impact of each such factor or the extent to which any factor,
or combination of factors, may cause results to differ materially
from those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211012005430/en/
Investor Relations Eric Balshin +1 437-826-9911
eric@sophiccapital.com
Company Contact: Jason Mitchell, N.D. Chief Executive
Officer and Director ir@hempfusion.com
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Aug 2024 to Sep 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Sep 2023 to Sep 2024